Gene · 143384
Papers3,620
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,620
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-κB inflammatory signaling. | Inflamm Res | 2026 | 42802181 | PubTator, text mining | PubMed |
| L013 promotes NRF2 degradation in NRFA-subtype esophageal squamous cell carcinoma. | Cell Rep Med | 2026 | 42727581 | PubTator, text mining | PubMed |
| Neddylation as a molecular integrator of metabolic dysfunction and endothelial dysfunction in type 2 diabetes. | Acta Pharmacol Sin | 2026 | 42637928 | PubTator, text mining | PubMed |
| Neddylation-dependent RAB40-Cullin5 E3 ligase complex controls ubiquitin-mediated proteasomal degradation of DNAJC13. | BBA Adv | 2026 | 42602476 | PubTator, text mining | PubMed |
| Structure-Based Discovery of JN210 as a Potent Dual DCN1/HDAC Inhibitor for the Treatment of Nonsmall Cell Lung Cancer. | J Med Chem | 2026 | 42593931 | PubTator, text mining | PubMed |
| Evidence that S-phase kinase associated protein 2 (SKP2) is ubiquitinated and degraded via a Rho-related BTB domain containing 1 (RhoBTB1) and Cullin-3 mechanism in placenta. | Physiol Rep | 2026 | 42552612 | PubTator, text mining | PubMed |
| CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression. | Front Immunol | 2026 | 42535029 | PubTator, text mining | PubMed |
| Genome-Wide Characterization of the F-Box Gene Family in Cardamine hupingshanensis and Functional Analysis of ChFBX171. | Biology (Basel) | 2026 | 42450551 | PubTator, text mining | PubMed |
| E3 ligase LMO7 promotes ALKBH2 ubiquitination to sensitize MGMT-deficient glioblastoma to temozolomide. | Cell Death Dis | 2026 | 42380110 | PubTator, text mining | PubMed |
| Native Mass Spectrometry Analysis of Cullin-RING Ubiquitin E3 Ligase Complexes in the Context of Targeted Protein Degradation. | Anal Chem | 2026 | 42378227 | PubTator, text mining | PubMed |
| Identifying Neddylation-modified features to assess prognosis and immune efficacy in hepatocellular carcinoma. | Apoptosis | 2026 | 42178458 | PubTator, text mining | PubMed |
| A Global Ligandability Map of Tryptoline Butynamide Stereoprobes Identifies Covalent Inhibitors of the Actin Maturation Protease. | J Am Chem Soc | 2026 | 42159598 | PubTator, text mining | PubMed |
| CRL4AMBRA1-mediated progesterone receptor degradation drives progestin resistance and represents a therapeutic vulnerability in endometrial cancer. | Int J Biol Sci | 2026 | 42157930 | PubTator, text mining | PubMed |
| Exosomal circRNA_0023016 suppresses hepatocellular carcinoma progression by regulating the EIF4A3/RNF113A/CXCR4 axis in endothelial cells. | Int Immunopharmacol | 2026 | 42119231 | PubTator, text mining | PubMed |
| Variants in KLHL15, encoding a regulator of protein ubiquitination, linked to focal epilepsy with neurodevelopmental disorders. | Seizure | 2026 | 42097059 | PubTator, text mining | PubMed |
| Interface Architecture of a VHL-PROTAC Complex with and without Cullin-2. | J Am Chem Soc | 2026 | 42089481 | PubTator, text mining | PubMed |
| TTLL12 counteracts BPOZ-2 to stabilize eEF1A1 and promote hepatocarcinogenesis. | Cell Death Dis | 2026 | 42014684 | PubTator, text mining | PubMed |
| Template-driven scaffolding of SCFFBXO42 regulates PP2A degradation. | Nature | 2026 | 41986709 | PubTator, text mining | PubMed |
| DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding Site. | ACS Med Chem Lett | 2026 | 41982729 | PubTator, text mining | PubMed |
| Natural product PROTACylation: Development of Maslinic acid-based JAK2 degraders for cancer therapy. | Fitoterapia | 2026 | 41876032 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/143384/papers